The darkening cloud of diabetes do Trends in cardiovascular risk management provide a silver lining?

Diabetes Care

Volumn 31, Issue 11, 2008, Pages 2136-2142

  Eurich, Dean T ^a   Gamble, John Michael ^a   Simpson, Scot H ^a   Johnson, Jeffrey A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; DIABETES MELLITUS; DIABETIC PATIENT; DRUG UTILIZATION; FEMALE; HEALTH CARE UTILIZATION; HEART DEATH; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK MANAGEMENT; SEX DIFFERENCE; STANDARD; EVIDENCE BASED MEDICINE; METHODOLOGY; MIDDLE AGED; MORTALITY; RISK ASSESSMENT; RISK FACTOR; STATISTICS; SURVIVAL RATE;

AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SASKATCHEWAN; SURVIVAL RATE;

EID: 59249095558     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1248     Document Type: Article

References (25)

1. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053, 2004
2. Lipscombe LL, HuxJE: Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet 369:750-756, 2007
3. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H: Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44 (Suppl. 2):S14-S21, 2001
4. World Health Organization: Global strategy on diet, physcial activity and health: diabetes [article online], 2008. Available from http://www.who.int/ dietphysicalactivity/publications/facts/diabetes/en/print.html. Accessed 8 April 2008
5. Huang ES, Meigs JB, Singer DE: The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med 111:633-642, 2001
6. McAlister FA, Campbell NRC, Duong- Hua M, Chen Z, Tu K: Antihypertensive medication prescribing in 27,822 elderly Canadians with diabetes over the past decade. Diabetes Care 29:836-841, 2006
7. Cohen FJ, Neslusan CA, ConklinJE, Song X: Recent antihyperglycemic prescribing trends for U.S. privately insured patients with type 2 diabetes. Diabetes Care 26: 1847-1851, 2003
8. Lusignan S, Sismanidis C, Carey IM, DeWilde S, Richards N, Cook DG: Trends in the prevalence and management of diagnosed type 2 diabetes 1994-2001 in England and Wales. BMC Fam Pract 6:13, 2005
9. Teeling M, Bennett K, Feely J: The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002. Br J Clin Pharmacol 59:227-232, 2005
10. Thomas RJ, Palumbo PJ, Melton LJ III, Roger VL, Ransom J, O'Brien PC, Leibson CL: Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med 163:445-451, 2003
11. Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC: Mortality trends in men and women with diabetes, 1971 to 2000. Ann InternMed 147:149-155, 2007
12. Tierney EF, Cadwell BL, Engelgau MM, Shireley L, Parsons SL, Moum K, Geiss LS: Declining mortality rate among people with diabetes in North Dakota, 1997-2002. Diabetes Care 27:2723-2725, 2004
13. FoxCS, CoadyS, Sorlie PD, LevyD, Meigs JB, D'Agostino RB Sr, Wilson PW, Savage PJ: Trends in cardiovascular complications of diabetes. JAMA 292:2495-2499, 2004
14. Stovring H, Andersen M, Beck-Nielsen H, Green A, Vach W: Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. Lancet 362:537-538, 2003
15. Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA: Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care 28:2345-2351, 2005
16. Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25: 512-516, 2002
17. Wang J, Williams DE, Narayan KM, Geiss LS: Declining death rates from hyperglycemic crisis among adults with diabetes, U.S., 1985-2002. Diabetes Care 29:2018- 2022, 2006
18. Kanjilal S, Gregg EW, Cheng YJ, Zhang P, Nelson DE, Mensah G, Beckles GL: Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch Intern Med 166:2348-2355, 2006
19. Hajjar I, Kotchen TA: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290:199-206, 2003
20. Imperatore G, Cadwell BL, Geiss L, Saad- inne JB, Williams DE, Ford ES, Thompson TJ, Narayan KM, Gregg EW: Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. Am J Epidemiol 160: 531-539, 2004
21. Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291-1297, 1999
22. Pavkov ME, Sievers ML, Knowler WC, Bennett PH, Nelson RG: An explanation for the increase in heart disease mortality rates in diabetic Pima Indians: effect of renal replacement therapy. Diabetes Care 27:1132-1136, 2004
23. Hoehner CM, Williams DE, Sievers ML, Knowler WC, Bennett PH, Nelson RG: Trends in heart disease death rates in diabetic and nondiabetic PimaIndians. J Diabetes Complications 20:8 -13, 2006
24. Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Imperatore G, Narayan KM: Improvements in diabetes processes of care and intermediate outcomes: United States, 1988 -2002. Ann Intern Med 144:465-474, 2006
25. Centers for Disease Control and Prevention: Prevalence of diabetes and impaired fasting glucose: United States, 1999 -2000. MMWR. Morbidity and Mortality Weekly Report 52:833-837, 2003